Denali Therapeutics shares owned by ClariVest Asset Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by ClariVest Asset Management
from 13F filings
Historical chart of ClariVest Asset Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by ClariVest Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by ClariVest Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $885k | 43k | 20.63 |
| 2023-06-30 | $1.3M | 43k | 29.51 |
| 2023-03-31 | $1.1M | 49k | 23.06 |
| 2022-12-31 | $1.4M | 49k | 27.79 |
| 2022-09-30 | $1.5M | 49k | 30.66 |
| 2022-06-30 | $1.6M | 55k | 29.41 |
| 2022-03-31 | $2.1M | 66k | 32.16 |
| 2021-12-31 | $2.9M | 66k | 44.59 |
| 2021-09-30 | $3.6M | 72k | 50.46 |
| 2021-06-30 | $5.9M | 75k | 78.44 |
| 2021-03-31 | $982k | 17k | 57.07 |
| 2020-12-31 | $1.4M | 17k | 83.79 |
| 2020-09-30 | $1.4M | 40k | 35.80 |
| 2020-06-30 | $757k | 31k | 24.16 |
More positions owned by ClariVest Asset Management
View all positions for ClariVest Asset Management